Downstream demand helps Millipore’s Q2
Demand for downstream processing products from biotechs drove the continued recovery of Millipore’s bioprocessing division in Q2 but operating income remained flat.
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs